Nexalin Technology Inc [NXL] stock prices are up 16.30% to $3.21 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The NXL shares have gain 17.58% over the last week, with a monthly amount drifted -21.80%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of Nexalin Technology Inc [NXL] has been fluctuating between $0.25 and $4.49 over the past year. Nexalin Technology Inc [NASDAQ: NXL] shares were valued at $3.21 at the most recent close of the market.
Analyzing the NXL fundamentals
The Nexalin Technology Inc [NASDAQ:NXL] reported sales of 0.16M for trailing twelve months, representing a surge of 49.43%. Gross Profit Margin for this corporation currently stands at -5.73% with Operating Profit Margin at -40.13%, Pretax Profit Margin comes in at -34.27%, and Net Profit Margin reading is -34.27%. To continue investigating profitability, this company’s Return on Assets is posted at -1.06, Equity is -1.88 and Total Capital is -1.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.99 points at the first support level, and at 2.77 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.44, and for the 2nd resistance point, it is at 3.67.
Ratios To Look Out For
It’s worth pointing out that Nexalin Technology Inc [NASDAQ:NXL]’s Current Ratio is 16.39. As well, the Quick Ratio is 15.86, while the Cash Ratio is 0.27. Considering the valuation of this stock, the price to sales ratio is 266.92, the price to book ratio is 8.33.
Transactions by insiders
Recent insider trading involved Owens David, Chief Medical Officer, that happened on Oct 28 ’24 when 500.0 shares were purchased. Chief Medical Officer, Owens David completed a deal on Aug 13 ’24 to buy 1000.0 shares. Meanwhile, Chief Medical Officer Owens David bought 1000.0 shares on Jun 28 ’24.
